Common drug shows promise for slowing kidney decline
NCT ID NCT07315139
First seen Jan 11, 2026 · Last updated Jun 11, 2026 · Updated 24 times
Summary
This study looked at whether pentoxifylline, a drug used for blood flow issues, could lower inflammation and slow the progression of chronic kidney disease in non-diabetic patients. Researchers measured inflammatory markers in 42 adults with moderate kidney disease. The goal was to see if this treatment could help control the disease and prevent further kidney damage.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Ain Shams University
Cairo, 11591, Egypt
Conditions
Explore the condition pages connected to this study.